FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/085605 [Registered on: 24/04/2025] Trial Registered Prospectively
Last Modified On: 16/04/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Single Arm Study 
Public Title of Study   : study to access laser to posterior capsule in laser assisted cataract surgery patients  
Scientific Title of Study   A prospective, randomized, pilot, comparative clinical study to assess Primary Posterior Capsulotomy with Femto LDV Z8 in patients undergoing cataract surgery(FLACS). 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrSriganesh 
Designation  Chief Medical Director 
Affiliation  Nethradhama Super Speciality Eye Hospital  
Address  256/14, Nethradhama Super Speciality Eye Hospital, Kanakapura main road, Jayanagar 7th block, Bengaluru Bangalore KARNATAKA 560070 India

Bangalore
KARNATAKA
560070
India 
Phone  9845129740  
Fax    
Email  phacomaverick@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrsushmithsSriganesh 
Designation  Chief Research Officer 
Affiliation  Nethradhama Super Speciality Eye Hospital  
Address  256/14, Nethradhama Super Speciality Eye Hospital, Kanakapura main road, Jayanagar 7th block, Bengaluru Bangalore KARNATAKA 560070 India

Bangalore
KARNATAKA
560070
India 
Phone  9448071800  
Fax    
Email  sush.samak@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrPavithra priyadarshini P R 
Designation  phaco refractive surgery fellows 
Affiliation  Nethradhama Super Speciality Eye Hospital  
Address  256/14, Nethradhama Super Speciality Eye Hospital, Kanakapura main road, Jayanagar 7th block, Bengaluru Bangalore KARNATAKA 560070 India

Bangalore
KARNATAKA
560070
India 
Phone  9591723727  
Fax    
Email  prpavithrapriyadarshini@gmail.com  
 
Source of Monetary or Material Support  
256/14, Nethradhama Super Speciality Eye Hospital, Kanakapura main road, Jayanagar 7th block, Bengaluru Bangalore 
 
Primary Sponsor  
Name  Nethradhama Super Speciality Eye Hospital 
Address  256/14, Nethradhama Super Speciality Eye Hospital, Department of Phaco refractive surgery, Kanakapura main road, Jayanagar 7th block, Bengaluru Bangalore 
Type of Sponsor  Private hospital/clinic 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrPavithra priyadarshini P R  Nethradhama Super Speciality Eye Hospital  256/14, Department of Phacorefractive surgery, Kanakapura main road, Jayanagar 7th block, Bengaluru Bangalore KARNATAKA
Bangalore
KARNATAKA 
9591723727

prpavithrapriyadarshini@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
NETHRADHAMA SUPERSPECIALITY EYE HOSPITAL INSTITUTIONAL ETHICS COMMITTEE   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H259||Unspecified age-related cataract,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  cataract surgery(FLACS) Patient  cataract surgery(FLACS) Patient without Primary Posterior Capsulotomy with Femto LDV Z8 
Intervention  Primary Posterior Capsulotomy with Femto LDV Z8 in patients undergoing cataract surgery(FLACS)  During the proposed pilot phase, a group undergoing FLACS with systematic posterior capsulotomy with the Femtosecond Laser Femto LDV Z8 (Ziemer Ophthalmic Systems AG, Port, Switzerland) will be compared to a control group undergoing FLACS without posterior capsulotomy. 
 
Inclusion Criteria  
Age From  45.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  Age-related Cataract
Best corrected Visual Acuity of not more than 6by 7.5
Nuclear Sclerotic Cataract
Lens opacification which can be graded on the LOCS III scale with NC Grade 1 or higher (20) with cc and PSC
Patients with eyes which are anatomically suitable to undergo FLACS with the Ziemer Femto LDV Z8
 
 
ExclusionCriteria 
Details  Previous history of ocular pathologies, such as Age-related Macular Degeneration, Diabetic Retinopathy, any type of Glaucoma, Uveitis, Ocular Tumor
Previous Ocular Surgery
Corneal Opacities such as scars, ulcers, or related to endothelial dystrophy
Pupil diameter of less than 6 mm or intraoperative floppy-iris syndrome
Issues related to general health condition, such as uncontrolled diabetes, cardiovascular diseases, chronic kidney disease, uncontrolled hypertension
Concurrent participation in another clinical study
Weak zonules , subluxated Cataractous lens and PPC
Operative complications, including posterior capsular tear, zonular dialysis, lens drop in vitreous.
 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
provide valuable insights into whether this approach could offer a safer alternative for managing PCO, thereby improving patient outcomes and expanding the preventive and therapeutic options available for cataract surgery patients and to optimize surgical and laser parameters and provide a first evaluation in terms of safety and efficacy.  postoperative days 1, 14, and 45 days 
 
Secondary Outcome  
Outcome  TimePoints 
ascertain occurrence of common complications in Nd:YAG posterior capsulotomy.   postoperative days 1, 14, and 45 days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   28/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Institutional Ethics committee approval will be obtained and trial registered with Clinical Trial Registry of India. Patients informed consent will be taken and the procedure explained to them in their own language.

During the proposed pilot phase, a group undergoing FLACS with systematic posterior capsulotomy with the Femtosecond Laser Femto LDV Z8 (Ziemer Ophthalmic Systems AG, Port, Switzerland) will be compared to a control group undergoing FLACS without posterior capsulotomy.

Study design: prospective, pilot, randomized, comparative, hospital-based, single centerinterventional clinical study

Study Population: Patients undergoing cataract surgery (FLACS) with Primary Posterior Capsulotomy with Femto LDV Z8.

Study Setting: Nethradhama Superspeciality Eye Hospital, Bangalore.

Patient selection criteria:Patients will be enrolled into the clinical study and randomized in a ratio of 1:1 in a sequential manner as per the discretion of the Investigator. The patients will also be willing to attend routine follow-up care as described below (1 day up to 6 weeks post-surgery).

Study Duration: Time frame for patient visits and examination are pre-operative, day of surgery, postoperative days 1, 14, and 45 days

Before the surgery, all patients will undergo a complete ophthalmic examination including UVCA BCVA manifest refraction, slit lamp biomicroscopy, noncontact tonometry (Topcon CT-80), and macular OCT(Optovue, Fremont, USA) AS OCT and dilated fundus examination.

Surgical procedure:

Patients will undergo monocular FLACS with the Femto LDV Z8. At random, a patient to be treated will be assigned to the control group or to the group where posterior capsulotomy will be performed using the Femto LDV Z8.

In both groups, the laser will be used to perform anterior capsulotomy and corneal incisions. The surgery algorithm up until to the point at which the IOL is implanted does not differ between the groups. The surgeon will then ensure the corneal incisions are sealing the anterior chamber. Surgeon will place a small amount of viscoelastic between the IOL and the posterior capsule to prevent IOL damage.

For those eyes assigned to the posterior capsulotomy group, the suction ring of the laser will be docked. After suction is achieved, the surgeon checks again that the corneal incision is sealed. After docking the handpiece of the Femto LDV Z8, the surgeon will grade the visibility of the anterior hyaloid on a scale from 0 to 3, where 0 corresponds to no visibility of the anterior hyaloid and 3 corresponds to excellent visibility of the entire Berger Space. The surgeon will then ensure that the cut placement of the posterior capsulotomy is in accordance with the surgical plan. In case satisfying placement of the posterior capsulotomy is not possible, suction will be aborted and the eye will drop out of the study.

After the cut, the surgeon will grade the cut quality of the posterior capsulotomy based on the following criteria:

1.     Tagging or incomplete cuts: The surgeon will grade the cut quality on a scale ranging from 0 to 3, defined the following way:

a.     Value 0 corresponds to a partial cut which is impossible to remove manually

b.     Value 1 corresponds to a circular cut with tags or uncut areas, but it is still possible to remove manually

c.     Value 2 corresponds to a complete cut with filaments.

d.     Value 3 corresponds to a complete circular cut with a free-floating posterior capsulotomy

2.     Capsulotomy Diameter Accuracy:  The surgeon measures the diameter of the posterior capsulotomy. This value will then be compared to the planned value. In case of an elliptic shape, the surgeon will measure both major axes.

3.     Edge Quality: Surgeon will grade smoothness on a scale ranging from 0 to 3, defined the following way:

a.     Grade 0 corresponds to significant irregularities with pronounced jagged or torn edges

b.     Grade 1 corresponds to moderate irregularities with some jagged edges

c.     Grade 2 corresponds to minor irregularities which will not affect the visual outcome

d.     Grade 3 corresponds to a perfectly smooth edge

Finally, the surgeon will use the irrigation/aspiration probe of the phacoemulsifier to remove the posterior capsulotomy if possible.

Method of data collection:

Data will be collected on the demographic profile (age, gender, address, and occupation) and ocular parameters of the patients, as measured by slit lamp examination, 90D lens with slit lamp, and indirect ophthalmoscopy.

Before the surgery, all patients will undergo a complete ophthalmic examination including UVCA BCVA manifest refraction, slit lamp biomicroscopy, noncontact tonometry (Topcon CT-80), and macular OCT(Optovue, Fremont, USA) AS OCT and dilated fundus examination

The following tests will be performed pre-operatively:

1.     Detailed slit lamp and dilated fundus examination

2.     Uncorrected Distance Visual Acuity (UDVA)

3.     Corrected Distance Visual Acuity (CDVA)

4.     Manifest refraction

5.     Non contact tonometry (Topcon CT-80 )

6.     Macular OCT(Optovue, Fremont, USA)

7.     AS OCT

Intra-operative data:

1.     Total Operation time- from first incision to sealing the wound

2.     Effective Phaco Time- time from start of phaco till complete nucleus removal

3.     Amount of OVD injected posterior to IOL – in ml/cc

 

 

Post-operatively on day 1, 2 weeks, 6weeks the following tests will be conducted.

 

1.     Slit lamp examination

2.     Uncorrected distance Visual Acuity(UDVA)

3.     Corrected Distance Visual Acuity (CDVA)

4.     Manifest refraction

5.     Non contact tonometry (Topcon CT-80 )

6.     Macular OCT(Optovue, Fremont, USA)

7.     AS OCT (MS-39)- Evaluate IOL position and tilt

8.     Dilated fundus examination was seen at 6 weeks

9.     Subjective questionnaire

 
Close